How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?
<h4>Background</h4>Onchocerciasis (river-blindness) in Africa is targeted for elimination through mass drug administration (MDA) with ivermectin. Onchocerciasis may cause various types of skin and eye disease. Predicting the impact of MDA on onchocercal morbidity is useful for future pol...
Guardado en:
Autores principales: | Natalie V S Vinkeles Melchers, Wilma A Stolk, Michele E Murdoch, Belén Pedrique, Marielle Kloek, Roel Bakker, Sake J de Vlas, Luc E Coffeng |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/67c3e503d2574b8d9810145e9f64d819 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for 1990, 2020, and 2030.
por: Natalie V S Vinkeles Melchers, et al.
Publicado: (2021) -
African Programme For Onchocerciasis Control 1995-2015: model-estimated health impact and cost.
por: Luc E Coffeng, et al.
Publicado: (2013) -
Predicting the environmental suitability for onchocerciasis in Africa as an aid to elimination planning.
por: Elizabeth A Cromwell, et al.
Publicado: (2021) -
Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis.
por: Hugo C Turner, et al.
Publicado: (2013) -
Impact of three rounds of mass drug administration on lymphatic filariasis in areas previously treated for onchocerciasis in Sierra Leone.
por: Joseph B Koroma, et al.
Publicado: (2013)